生命科學業務流程外包市場：按服務類型、最終用戶和地區分類

預計到 2026 年，生命科學業務流程外包 (BPO) 市場規模將達到 5,257.7 億美元，到 2033 年將達到 1.28,365 兆美元。預計從 2026 年到 2033 年，該市場將以 13.6% 的複合年成長率成長。

生命科學業務流程外包 (BPO) 市場涵蓋為製藥、生技、醫療設備公司以及其他醫療保健產業公司提供的外包服務。這使得生命科學公司能夠專注於藥物發現、產品開發和商業化等核心業務。諸如法規事務、臨床資料管理、醫學寫作和出版、藥物安全檢測、醫學監察以及其他臨床試驗相關服務等任務則外包給專業的 BPO 服務提供者。由於成本最佳化、獲取先進的基礎設施和專業知識、複雜的法規結構以及對營運效率的需求等因素，生命科學領域的外包需求正在不斷成長。

市場動態

全球生命科學業務流程外包 (BPO) 市場的成長主要受生命科學公司日益成長的成本最佳化需求以及 BPO服務供應商提供的先進基礎設施和專業知識所帶來的益處所驅動。此外，近年來藥物研發和核准的法規結構日益複雜，導致企業需要將非核心職能外包。醫療保健產業的趨勢轉變，包括向價值驅動型醫療的轉型，也促使生命科學公司透過策略性外包來提高營運效率。然而，資料安全問題、對關鍵職能的控制權喪失以及與供應商管理相關的營運挑戰等因素可能會阻礙市場成長。發展中地區醫療保健支出的成長、生物相似藥和基因組藥物的研發，以及人工智慧和區塊鏈技術在 BPO 服務中的應用，都為市場成長提供了潛在的機會。

本次調查的主要特點

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本研究根據以下參數創建了全球生命科學 BPO 市場主要公司的概況：公司亮點、產品系列、主要特徵、財務表現和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 這份全球生命科學業務流程外包市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
• 相關人員可以透過各種用於分析全球生命科學 BPO 市場的策略矩陣輕鬆做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 機會
• 影響分析
• 市場趨勢
• 主要進展
• 監管趨勢
• 收購與合作趨勢
• 資金籌措及投資
• PEST分析
• 波特的分析

第4章 全球生命科學業務流程外包市場：依服務類型分類，2021-2033年

• 概述
• 醫藥外包
• 醫療設備外包
• 合約銷售和市場外包
• 其他

第5章 全球生命科學業務流程外包市場：依最終用戶分類，2021-2033年

• 概述
• 製藥公司
• 生技公司
• 受託研究機構
• 醫療設備製造商
• 學術機構及政府機構

第6章 全球生命科學業務流程外包市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第7章 競爭情勢

• 公司簡介
  • Accenture, Plc
  • Boehringer Ingelheim GmbH
  • Cognizant Technology Solutions
  • Infosys
  • Genpact Limited
  • ProMab Biotechnologies, Inc
  • Charles River Laboratories International, Inc.
  • Catalent, Inc.
  • Covance, Inc.
  • Fareva
  • ICON, Plc
  • DSM
  • Health Decisions, Inc.
  • IQVIA
  • Laboratory Corporation of America Holdings
  • Syneos Health, Inc.
  • Parexel International Corporation
  • PRA Health Sciences

第8章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第9章 參考文獻與調查方法

• 參考
• 調查方法

Life Sciences Bpo Market is estimated to be valued at USD 525.77 Bn in 2026 and is expected to reach USD 1,283.65 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2026 to 2033.

The life sciences BPO market comprises outsourcing services provided to pharmaceutical, biotechnology, medical device companies and others in the healthcare industry. It helps life sciences companies to focus on core activities of drug discovery, product development and commercialization. Services like regulatory affairs management, clinical data management, medical writing and publishing, pharmacovigilance, medical monitoring and other clinical trial related services are outsourced to specialized BPO players. Factors such as cost optimization, access to advanced infrastructure and expertise, complex regulatory frameworks and need to streamline operations has increased outsourcing in the life sciences sector.

Market Dynamics

Global life sciences BPO market growth is driven by rising need for cost-optimization among life sciences companies coupled with benefits of access to advanced infrastructure and expertise delivered by BPO service providers. Moreover, regulatory frameworks for drug development and approval have become highly complex over the years, thus, necessitating outsourcing of non-core functionalities. Changing dynamics of the healthcare industry including shift towards value-based care has also prompted life sciences players to streamline their operations through strategic outsourcing. However, factors such as data security concerns, loss of control over critical functions and operational challenges associated with vendor management can hamper the market growth. Growing healthcare expenditure in developing regions, development of biosimilars & genomic drugs and integration of AI/blockchain to enhance BPO services can offer market growth opportunities.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global life sciences BPO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Cognizant, Accenture, Genpact, EXL services, and Catalent.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global life sciences BPO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global life sciences BPO market.

Market Segmentation

• By Service Type (Revenue, USD Bn, 2021 - 2033)
• Pharmaceutical outsourcing
  • Contract manufacturing market
    • API
    • Finished dose form
    • Packaging
  • Contract research organizations
    • Drug discovery
    • Preclinical studies
    • Clinical trial studies
    • Regulatory services
    • Pharmacovigilance
• Medical devices outsourcing
  • Contract manufacturing market
    • Electronic manufacturing services
    • Finished goods
    • Raw materials/components
  • Contract research organizations
    • Regulatory consulting services
    • Product design and development services
    • Product testing services
    • Product implementation services
    • Product upgrade services
    • Product maintenance services
• Contract sales & market outsourcing
• Others
• By End User (Revenue, USD Bn, 2021 - 2033)
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations Medical Device Companies
• Academic Institutes & Government Organizations
• By Region (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Company Profiles
• Accenture, Plc
• Boehringer Ingelheim GmbH
• Cognizant Technology Solutions
• Infosys
• Genpact Limited
• ProMab Biotechnologies, Inc.
• Charles River Laboratories International, Inc.
• Catalent, Inc.
• Covance, Inc.
• Fareva
• ICON, Plc
• DSM
• Health Decisions, Inc.
• IQVIA
• Laboratory Corporation of America Holdings
• Syneos Health, Inc.
• Parexel International Corporation
• PRA Health Sciences

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Service Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Life Sciences BPO Market, By Service Type, 2021 - 2033, (USD Bn)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Pharmaceutical outsourcing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Contract manufacturing market
    • API
    • Finished dose form
    • Packaging
  • Contract research organizations
    • Drug discovery
    • Preclinical studies
    • Clinical trial studies
    • Regulatory services
    • Pharmacovigilance
• Medical devices outsourcing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Contract manufacturing market
    • Electronic manufacturing services
    • Finished goods
    • Raw materials/components
  • Contract research organizations
    • Regulatory consulting services
    • Product design and development services
    • Product testing services
    • Product implementation services
    • Product upgrade services
    • Product maintenance services
• Contract sales & market outsourcing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Life Sciences BPO Market, By End User, 2021 - 2033, (USD Bn)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Pharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Biotechnology Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Contract Research Organizations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Medical Device Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Academic Institutes & Government Organizations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Life Sciences BPO Market, By Region, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

• Company Profiles
  • Accenture, Plc
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim GmbH
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cognizant Technology Solutions
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Infosys
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Genpact Limited
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ProMab Biotechnologies, Inc
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Charles River Laboratories International, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Catalent, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Covance, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Fareva
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ICON, Plc
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • DSM
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Health Decisions, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • IQVIA
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Laboratory Corporation of America Holdings
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Syneos Health, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Parexel International Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • PRA Health Sciences
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

8. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

9. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact